Big Data in the Pharmaceutical Sector between Protection and Transparency: Opportunities and Legal Challenges

Lexxion organises conferences, workshops, seminars and trainings in various fields of law all over Europe. The events focus on State aid law, competition law, and ESI Funds, public procurement, PPP law, environmental and climate law, data protection law, food law, chemical law and pharmaceutical law. Our events address the issues of legal compliance, financial management and audit, combating fraud and corruption in the following sectors: agriculture, energy, environment, transport, infrastructure, R&D&I and technology, defence and financial and fiscal sectors.
You can also book tailor-made in-house trainings. Find an overview of all dates, topics and venues on this website.
Download Spring|Summer 2019 Events Broschure

Data in the healthcare and pharmaceutical sector play an important role in various aspects. Data has already transformed many facets of the sector. Huge datasets are driving new drug discoveries and are making clinical trials more efficient. Wearable devises such as sleep trackers are creating more informed patients and the employment of more sophisticated data models has enabled healthcare professionals better to predict and prevent illness. From personalised medicine to AI assisted diagnostics and genetic engineering and sequencing, the possibilities, it seems, are endless.

However, despite its potential to improve patient care and the share price of pharmaceutical companies, legal and regulatory challenges remain. One need to look no further than the recent introduction of the General Data Protection Regulation (GDPR) to realise that significant regulatory challenges exists. With patients and regulatory becoming increasingly cognizant of data protection issues, regulatory restrictions are only going to increase.

If you are interested, please use our Newletter to stay informed about our upcoming conferences, workshops, trainings and current published journals in our core areas of  EU competition, data protection, substances and environmental law, as well as exciting new projects in emerging technologies and digitalisation.

Don’t miss any news and sign up for our free news alert.  sign up now